The New York Times

Business Day

A Shift of Power in Pharmaceuticals: Manufacturers Yield To Managed Care
In an article written in 1996 by Milt Freudenheim for the New York Times, analyzing the then-current trend of pharmaceutical companies acquiring managed-care drug companies (PBMs), the lead principal of PGI was quoted in the concluding paragraph as saying:

"The name of the game in the future is going to be information." Referring to Martin Wygod, the founder of Medco, who is a Merck vice chairman, [Jan Buck] added: "Marty Wygod made $6 billion for himself because he developed a data base."

Back to Front Page

For all natural dermatology products, we recommend visiting our affiliated company, Xenna Corporation at